Kangmei Pharmaceutical Co (SHSE:600518) ROCE % : -0.14% (As of Sep. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Kangmei Pharmaceutical Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Kangmei Pharmaceutical Co's annualized ROCE % for the quarter that ended in Sep. 2024 was -0.14%.

Kangmei Pharmaceutical Co ROCE % Historical Data

The historical data trend for Kangmei Pharmaceutical Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kangmei Pharmaceutical Co ROCE % Chart

Kangmei Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

-10.83

-132.21

86.22

-24.82

1.72

Kangmei Pharmaceutical Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROCE %	Get a 7-Day Free Trial															-0.59	12.19	0.53	0.76	-0.14

Kangmei Pharmaceutical Co ROCE % Calculation

Kangmei Pharmaceutical Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	166.521	/	( ( (15168.579 - 5441.512)	+	(14280.379 - 4680.021) )	/ 2 )
	=	166.521	/	( (9727.067	+	9600.358)	/ 2 )
	=	166.521	/	9663.7125
	=	1.72 %

Kangmei Pharmaceutical Co's ROCE % of for the quarter that ended in Sep. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	-13.048	/	( ( (14257.004 - 4702.108)	+	(14193.607 - 4910.518) )	/ 2 )
	=	-13.048	/	( ( 9554.896	+	9283.089 )	/ 2 )
	=	-13.048	/	9418.9925
	=	-0.14 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

Kangmei Pharmaceutical Co (SHSE:600518) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Kangmei Pharmaceutical Co ROCE % Related Terms

Thank you for viewing the detailed overview of Kangmei Pharmaceutical Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Kangmei Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kangmei Pharmaceutical Co Ltd (SHSE:600518) » Definitions » ROCE %

Traded in Other Exchanges

N/A

Address

Taike Road, Xiameilin, Futian District, Guangdong, Shenzhen, CHN, 518000

Website

https://www.kangmei.com.cn

Kangmei Pharmaceutical Co Ltd is a pharmaceutical company engaged in the trading of Chinese herbal medicines, production and sales of Chinese herbal medicine slices, Chinese patent medicine preparations, health foods, chemical drugs and medical devices, modern pharmaceutical logistics system.

Executives

Xu Dong Jin	Director
Li Jian Hua	senior management
Qiu Xi Wei	Director
Wang Min	senior management
Peng Qin	senior management
Ma Xing Tian	Director
Lin Guo Xiong	senior management
Zhuang Yi Qing	senior management
Wen Shao Sheng	Supervisors

Kangmei Pharmaceutical Co Headlines

No Headlines